PMC:7144273 / 37853-38283 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T317","span":{"begin":146,"end":151},"obj":"Body_part"},{"id":"T318","span":{"begin":152,"end":174},"obj":"Body_part"},{"id":"T319","span":{"begin":169,"end":174},"obj":"Body_part"},{"id":"T320","span":{"begin":254,"end":262},"obj":"Body_part"},{"id":"T321","span":{"begin":257,"end":262},"obj":"Body_part"}],"attributes":[{"id":"A317","pred":"fma_id","subj":"T317","obj":"http://purl.org/sig/ont/fma/fma9670"},{"id":"A318","pred":"fma_id","subj":"T318","obj":"http://purl.org/sig/ont/fma/fma0326143"},{"id":"A319","pred":"fma_id","subj":"T319","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A320","pred":"fma_id","subj":"T320","obj":"http://purl.org/sig/ont/fma/fma63147"},{"id":"A321","pred":"fma_id","subj":"T321","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"1 14-02-2020; 20-02-2020 to 20-02-2021 0Not recruiting ChiCTR2000029816;http://www.chictr.org.cn/showproj.aspx?proj=49389 Clinical study for cord blood mesenchymal stem cells in the treatment of acute novel coronavirus pneumonia (COVID-19) UCB-MSCs; UCB-NK cells 60 Experimental groups: conventional treatment followed by i.v. infusion of 1) UCB-MSCs and 2) UCB-MSCs combined with UCB-NK cellsControl group: conventional treatment"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T114","span":{"begin":146,"end":151},"obj":"Body_part"}],"attributes":[{"id":"A114","pred":"uberon_id","subj":"T114","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"}],"text":"1 14-02-2020; 20-02-2020 to 20-02-2021 0Not recruiting ChiCTR2000029816;http://www.chictr.org.cn/showproj.aspx?proj=49389 Clinical study for cord blood mesenchymal stem cells in the treatment of acute novel coronavirus pneumonia (COVID-19) UCB-MSCs; UCB-NK cells 60 Experimental groups: conventional treatment followed by i.v. infusion of 1) UCB-MSCs and 2) UCB-MSCs combined with UCB-NK cellsControl group: conventional treatment"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T266","span":{"begin":219,"end":228},"obj":"Disease"},{"id":"T267","span":{"begin":230,"end":238},"obj":"Disease"}],"attributes":[{"id":"A266","pred":"mondo_id","subj":"T266","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"},{"id":"A267","pred":"mondo_id","subj":"T267","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"1 14-02-2020; 20-02-2020 to 20-02-2021 0Not recruiting ChiCTR2000029816;http://www.chictr.org.cn/showproj.aspx?proj=49389 Clinical study for cord blood mesenchymal stem cells in the treatment of acute novel coronavirus pneumonia (COVID-19) UCB-MSCs; UCB-NK cells 60 Experimental groups: conventional treatment followed by i.v. infusion of 1) UCB-MSCs and 2) UCB-MSCs combined with UCB-NK cellsControl group: conventional treatment"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T531","span":{"begin":0,"end":4},"obj":"http://purl.obolibrary.org/obo/CLO_0053001"},{"id":"T532","span":{"begin":146,"end":151},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"T533","span":{"begin":146,"end":151},"obj":"http://www.ebi.ac.uk/efo/EFO_0000296"},{"id":"T534","span":{"begin":152,"end":174},"obj":"http://purl.obolibrary.org/obo/CL_0000134"},{"id":"T535","span":{"begin":254,"end":262},"obj":"http://purl.obolibrary.org/obo/CL_0000623"}],"text":"1 14-02-2020; 20-02-2020 to 20-02-2021 0Not recruiting ChiCTR2000029816;http://www.chictr.org.cn/showproj.aspx?proj=49389 Clinical study for cord blood mesenchymal stem cells in the treatment of acute novel coronavirus pneumonia (COVID-19) UCB-MSCs; UCB-NK cells 60 Experimental groups: conventional treatment followed by i.v. infusion of 1) UCB-MSCs and 2) UCB-MSCs combined with UCB-NK cellsControl group: conventional treatment"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T175","span":{"begin":401,"end":406},"obj":"Chemical"}],"attributes":[{"id":"A175","pred":"chebi_id","subj":"T175","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"}],"text":"1 14-02-2020; 20-02-2020 to 20-02-2021 0Not recruiting ChiCTR2000029816;http://www.chictr.org.cn/showproj.aspx?proj=49389 Clinical study for cord blood mesenchymal stem cells in the treatment of acute novel coronavirus pneumonia (COVID-19) UCB-MSCs; UCB-NK cells 60 Experimental groups: conventional treatment followed by i.v. infusion of 1) UCB-MSCs and 2) UCB-MSCs combined with UCB-NK cellsControl group: conventional treatment"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T49","span":{"begin":219,"end":228},"obj":"Phenotype"}],"attributes":[{"id":"A49","pred":"hp_id","subj":"T49","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"1 14-02-2020; 20-02-2020 to 20-02-2021 0Not recruiting ChiCTR2000029816;http://www.chictr.org.cn/showproj.aspx?proj=49389 Clinical study for cord blood mesenchymal stem cells in the treatment of acute novel coronavirus pneumonia (COVID-19) UCB-MSCs; UCB-NK cells 60 Experimental groups: conventional treatment followed by i.v. infusion of 1) UCB-MSCs and 2) UCB-MSCs combined with UCB-NK cellsControl group: conventional treatment"}

{"project":"LitCovid-sentences","denotations":[{"id":"T176","span":{"begin":0,"end":430},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"1 14-02-2020; 20-02-2020 to 20-02-2021 0Not recruiting ChiCTR2000029816;http://www.chictr.org.cn/showproj.aspx?proj=49389 Clinical study for cord blood mesenchymal stem cells in the treatment of acute novel coronavirus pneumonia (COVID-19) UCB-MSCs; UCB-NK cells 60 Experimental groups: conventional treatment followed by i.v. infusion of 1) UCB-MSCs and 2) UCB-MSCs combined with UCB-NK cellsControl group: conventional treatment"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1339","span":{"begin":122,"end":130},"obj":"Species"},{"id":"1355","span":{"begin":201,"end":228},"obj":"Disease"},{"id":"1356","span":{"begin":230,"end":235},"obj":"Disease"}],"attributes":[{"id":"A1339","pred":"tao:has_database_id","subj":"1339","obj":"Tax:191496"},{"id":"A1355","pred":"tao:has_database_id","subj":"1355","obj":"MESH:C000657245"},{"id":"A1356","pred":"tao:has_database_id","subj":"1356","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"1 14-02-2020; 20-02-2020 to 20-02-2021 0Not recruiting ChiCTR2000029816;http://www.chictr.org.cn/showproj.aspx?proj=49389 Clinical study for cord blood mesenchymal stem cells in the treatment of acute novel coronavirus pneumonia (COVID-19) UCB-MSCs; UCB-NK cells 60 Experimental groups: conventional treatment followed by i.v. infusion of 1) UCB-MSCs and 2) UCB-MSCs combined with UCB-NK cellsControl group: conventional treatment"}